Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Edward Boyer MD, PhD

    TitleProfessor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentEmergency Medicine
    AddressUniversity of Massachusetts Medical School
    55 Lake Avenue North
    Worcester MA 01655
    Phone508-856-4101
      Other Positions
      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentMasters in Clinical Investigation

      InstitutionUMMS - Programs, Centers and Institutes
      DepartmentCenter for AIDS Research

        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Haran JP, Hoaglin DC, Chen H, Boyer EW, Lu S. Antigen-specific H1N1 influenza antibody responses in acute respiratory tract infections and their relation to influenza infection and disease course. J Clin Virol. 2014 Aug; 60(4):367-73.
          View in: PubMed
        2. Burns JM, Boyer EW. Antitussives and substance abuse. Subst Abuse Rehabil. 2013; 4:75-82.
          View in: PubMed
        3. Neavyn MJ, Boyer EW, Bird SB, Babu KM. Sodium acetate as a replacement for sodium bicarbonate in medical toxicology: a review. J Med Toxicol. 2013 Sep; 9(3):250-4.
          View in: PubMed
        4. Burns JM, Marino A, Manno M, Rhyee S, Boyer EW. Status epilepticus in a child secondary to ingestion of skin-lightening cream. Pediatr Emerg Care. 2013 May; 29(5):662-4.
          View in: PubMed
        5. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012 Jul 12; 367(2):146-55.
          View in: PubMed
        6. Rosenbaum CD, Boyle KL, Boyer EW. Nasopharyngeal necrosis after chronic opioid (oxycodone/acetaminophen) insufflation. J Med Toxicol. 2012 Jun; 8(2):240-1.
          View in: PubMed
        7. Zuckerman MD, Boyer EW. HIV and club drugs in emerging adulthood. Curr Opin Pediatr. 2012 Apr; 24(2):219-24.
          View in: PubMed
        8. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9.
          View in: PubMed
        9. Levine M, Curry SC, Ruha AM, Pizon AF, Boyer E, Burns J, Bikin D, Gerkin RD. Ethylene glycol elimination kinetics and outcomes in patients managed without hemodialysis. Ann Emerg Med. 2012 Jun; 59(6):527-31.
          View in: PubMed
        10. Weibrecht K, Rhyee S, Manuell ME, Longo C, Boyer EW, Brush E. Sulfur mustard exposure presenting to a community emergency department. Ann Emerg Med. 2012 Jan; 59(1):70-4.
          View in: PubMed
        11. Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW. Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. J Med Toxicol. 2011 Dec; 7(4):281-7.
          View in: PubMed
        12. Ward J, Szabo G, McManus D, Boyer E. Advanced molecular biologic techniques in toxicologic disease. J Med Toxicol. 2011 Dec; 7(4):288-94.
          View in: PubMed
        13. Ward J, Rosenbaum C, Hernon C, McCurdy CR, Boyer EW. Herbal medicines for the management of opioid addiction: safe and effective alternatives to conventional pharmacotherapy? CNS Drugs. 2011 Dec 1; 25(12):999-1007.
          View in: PubMed
        14. Ward J, Rhyee S, Plansky J, Boyer E. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin Toxicol (Phila). 2011 Nov; 49(9):874-5.
          View in: PubMed
        15. Levine M, Brooks DE, Truitt CA, Wolk BJ, Boyer EW, Ruha AM. Toxicology in the ICU: Part 1: general overview and approach to treatment. Chest. 2011 Sep; 140(3):795-806.
          View in: PubMed
        16. Wachholtz A, Gonzalez G, Boyer E, Naqvi ZN, Rosenbaum C, Ziedonis D. Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2011; 2:145-62.
          View in: PubMed
        17. Moore JO, Boyer EW, Safren S, Robbins GK, Boudreaux ED, Rosen R, Barton B, Moss F. Designing interventions to overcome poor numeracy and improve medication adherence in chronic illness, including HIV/AIDS. J Med Toxicol. 2011 Jun; 7(2):133-8.
          View in: PubMed
        18. Adkins JE, Boyer EW, McCurdy CR. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Curr Top Med Chem. 2011; 11(9):1165-75.
          View in: PubMed
        19. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6.
          View in: PubMed
        20. Gener B, Burns JM, Griffin S, Boyer EW. Administration of ondansetron is associated with lethal outcome. Pediatrics. 2010 Jun; 125(6):e1514-7.
          View in: PubMed
        21. Boyer EW, Fay RJ, Cook A, Buckosh M, Hibberd PL, Case P. Conducting drug abuse investigations in natural environments: potential directions for medical toxicology research. J Med Toxicol. 2010 Mar; 6(1):56-62.
          View in: PubMed
        22. Boyer EW, McCance-Katz EF, Marcus S. Methadone and buprenorphine toxicity in children. Am J Addict. 2010 Jan-Feb; 19(1):89-95.
          View in: PubMed
        23. Monte AA, Mandell T, Wilford BB, Tennyson J, Boyer EW. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J Addict Dis. 2009 Jul; 28(3):226-31.
          View in: PubMed
        24. Church RJ, Boyer EW. Case files of the Medical Toxicology Fellowship at the University of Massachusetts Medical Center in Worcester, Massachusetts: stumbling through a blue haze. J Med Toxicol. 2009 Mar; 5(1):40-5.
          View in: PubMed
        25. Babu KM, Rosenbaum CD, Boyer EW. Head CT in patient with metabolic acidosis. J Med Toxicol. 2008 Dec; 4(4):275-6.
          View in: PubMed
        26. Boyer EW, Wines JD. Impact of Internet pharmacy regulation on opioid analgesic availability. J Stud Alcohol Drugs. 2008 Sep; 69(5):703-8.
          View in: PubMed
        27. Courtney J, Boyer E. Case files of the University of Massachusetts fellowship in medical toxicology: lethal dose of opioids contained in an elastomeric capsule labeled as vancomycin. J Med Toxicol. 2008 Sep; 4(3):192-6.
          View in: PubMed
        28. Vitale C, George M, Sheroff A, Hernon C, Boyer E. Tracheal and bronchial obstruction following cyanoacrylate aspiration in a toddler. Clin Toxicol (Phila). 2008 Jul; 46(6):560-2.
          View in: PubMed
        29. Boyer EW, Babu KM, Adkins JE, McCurdy CR, Halpern JH. Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa korth). Addiction. 2008 Jun; 103(6):1048-50.
          View in: PubMed
        30. Ali FM, Boyer EW, Bird SB. Estimated risk of hepatotoxicity after an acute acetaminophen overdose in alcoholics. Alcohol. 2008 May; 42(3):213-8.
          View in: PubMed
        31. Babu KM, McCurdy CR, Boyer EW. Opioid receptors and legal highs: Salvia divinorum and Kratom. Clin Toxicol (Phila). 2008 Feb; 46(2):146-52.
          View in: PubMed
        32. Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care. 2007 Nov; 23(11):829-31.
          View in: PubMed
        33. Levine M, Boyer EW, Pozner CN, Geib AJ, Thomsen T, Mick N, Thomas SH. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007 Sep; 35(9):2071-5.
          View in: PubMed
        34. Boyer EW, Babu KM, Macalino GE, Compton W. Self-treatment of opioid withdrawal with a dietary supplement, Kratom. Am J Addict. 2007 Sep-Oct; 16(5):352-6.
          View in: PubMed
        35. Boyer EW, Lapen PT, Macalino G, Hibberd PL. Dissemination of psychoactive substance information by innovative drug users. Cyberpsychol Behav. 2007 Feb; 10(1):1-6.
          View in: PubMed
        36. Hernon C, Boyer EW, Christensen D, Sugarman S. Case files of the University of Massachusetts fellowship in medical toxicology: three patients with an industrial radiography source exposure. J Med Toxicol. 2006 Dec; 2(4):163-8.
          View in: PubMed
        37. Geib AJ, Babu K, Ewald MB, Boyer EW. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics. 2006 Oct; 118(4):1746-51.
          View in: PubMed
        38. Weizberg M, Su M, Mazzola JL, Bird SB, Brush DE, Boyer EW. Altered mental status from olanzapine overdose treated with physostigmine. Clin Toxicol (Phila). 2006; 44(3):319-25.
          View in: PubMed
        39. Levine MD, Boyer E. Hyperinsulinemia-euglycemia therapy: a useful tool in treating calcium channel blocker poisoning. Crit Care. 2006; 10(4):149.
          View in: PubMed
        40. Boyer E. Issues in the management of dietary supplement use among hospitalized patients. J Med Toxicol. 2005 Dec; 1(1):30-4.
          View in: PubMed
        41. Lai MW, Boyer EW, Kleinman ME, Rodig NM, Ewald MB. Acute arsenic poisoning in two siblings. Pediatrics. 2005 Jul; 116(1):249-57.
          View in: PubMed
        42. Bird SB, Orr PG, Mazzola JL, Brush DE, Boyer EW. Levofloxacin-related seizure activity in a patient with Alzheimer's disease: assessment of potential risk factors. J Clin Psychopharmacol. 2005 Jun; 25(3):287-8.
          View in: PubMed
        43. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17; 352(11):1112-20.
          View in: PubMed
        44. Cohen MH, Hrbek A, Davis RB, Schachter SC, Kemper KJ, Boyer EW, Eisenberg DM. Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United States. Arch Intern Med. 2005 Feb 14; 165(3):289-95.
          View in: PubMed
        45. Boyer EW, Shannon M, Hibberd PL. The Internet and psychoactive substance use among innovative drug users. Pediatrics. 2005 Feb; 115(2):302-5.
          View in: PubMed
        46. Quang LS, Levy HL, Law T, Desai MC, Maher TJ, Boyer EW, Shannon MW, Woolf AD. Laboratory diagnosis of 1,4-BD and GHB overdose by routine urine organic acid analysis. Clin Toxicol (Phila). 2005; 43(4):321-3.
          View in: PubMed
        47. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care. 2004 Dec; 20(12):858-63.
          View in: PubMed
        48. Brush DE, Boyer EW. Intravenous N-acetylcysteine for children. Pediatr Emerg Care. 2004 Sep; 20(9):649-50.
          View in: PubMed
        49. Brush DE, Bird SB, Boyer EW. Gamma-hydroxybutyrate use in older adults. Ann Intern Med. 2004 Jun 15; 140(12):W70-1.
          View in: PubMed
        50. Brush DE, Bird SB, Boyer EW. Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J Toxicol Clin Toxicol. 2004; 42(2):191-5.
          View in: PubMed
        51. Dickson EW, Bird SB, Gaspari RJ, Boyer EW, Ferris CF. Diazepam inhibits organophosphate-induced central respiratory depression. Acad Emerg Med. 2003 Dec; 10(12):1303-6.
          View in: PubMed
        52. Boyer EW, Shannon MW. Which drug tests in medical emergencies? Clin Chem. 2003 Mar; 49(3):353-4.
          View in: PubMed
        53. Tong T, Boyer EW. Club drugs, smart drugs, raves, and circuit parties: an overview of the club scene. Pediatr Emerg Care. 2002 Jun; 18(3):216-8.
          View in: PubMed
        54. Boyer EW, Kearney S, Shannon MW, Quang L, Woolf A, Kemper K. Poisoning from a dietary supplement administered during hospitalization. Pediatrics. 2002 Mar; 109(3):E49.
          View in: PubMed
        55. Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium channel blocker poisoning. Pediatr Emerg Care. 2002 Feb; 18(1):36-7.
          View in: PubMed
        56. Brown MJ, Shannon MW, Woolf A, Boyer EW. Childhood methanol ingestion treated with fomepizole and hemodialysis. Pediatrics. 2001 Oct; 108(4):E77.
          View in: PubMed
        57. Boyer EW, Quang L, Woolf A, Shannon M. Use of physostigmine in the management of gamma-hydroxybutyrate overdose. Ann Emerg Med. 2001 Sep; 38(3):346; author reply 347-8.
          View in: PubMed
        58. Boyer EW, Shannon M, Hibberd PL. Web sites with misinformation about illicit drugs. N Engl J Med. 2001 Aug 9; 345(6):469-71.
          View in: PubMed
        59. Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med. 2001 May 31; 344(22):1721-2.
          View in: PubMed
        60. Boyer EW, Quang L, Woolf A, Shannon M, Magnani B. Dextromethorphan and ecstasy pills. JAMA. 2001 Jan 24-31; 285(4):409-10.
          View in: PubMed
        61. Boyer EW, Mejia M, Woolf A, Shannon M. Severe ethylene glycol ingestion treated without hemodialysis. Pediatrics. 2001 Jan; 107(1):172-3.
          View in: PubMed
        62. Weber JE, Chudnofsky CR, Boczar M, Boyer EW, Wilkerson MD, Hollander JE. Cocaine-associated chest pain: how common is myocardial infarction? Acad Emerg Med. 2000 Aug; 7(8):873-7.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Edward's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572